Ingen appoints director of r&d

Aims to increase sales of in vitro diagnostic (IVD) kits

Ingen Biosciences, a French developer of advanced in vitro diagnostic kits for clinical use, has appointed Karine Mignon-Godefroy as director of research & development.

Mignon-Godefroy joins the firm to generate sales of its first proprietary in vitro diagnostic (IVD) kit. These IVD kits are based on the firm’s specialist knowledge in proteomics and expertise in synthesising new recombinant antigens. Mignon-Godefroy will be responsible for identifying clinically relevant recombinant antigens as potential markers for the detection of infectious diseases found in prosthetic replacements, and to develop innovative IVD kits for clinical use.

‘Dr Mignon-Godefroy’s 15 years’ experience in biotechnology, depth of knowledge and skills will be a major contribution to our on-going r&d efforts,’ said Jean-Pierre Hermet, chief executive of Ingen Biosciences. ‘Her arrival will also strengthen the team, which has made significant inroads into developing products based on innovative technologies.'

Mignon-Godefroy joins Ingen Biosciences from the blood virus division of Bio-Rad, a manufacturer and distributor of products for a range of technologies including proteomics, where she was director of international projects.

You may also like

Regulatory

Johnson & Johnson submits regulatory application for Tremfya to the European Medicines Agency

The submission included data from the Phase 3 QUASAR programme in ulcerative colitis and the Phase 3 GALAXI programme in Crohn’s disease, which each achieved their primary endpoints
Manufacturing

Owen Mumford’s near-term and net-zero targets approved by the SBTi

The company's long and short-term initiatives include the reduction of scope 1, 2 and 3 emissions by 42% by 2030, as well as reaching net-zero in greenhouse gas emissions
Manufacturing

Adare expands global handling & packaging capabilities

The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Manufacturing

CPI collaborates with industry leaders to expedite drug manufacturing via digitisation

Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Manufacturing

Making the most of each cell: single-use perfusion in biopharma processing

GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing, reports Ruediger Goehmann, Product Manager, Pharma/Chemicals, at GEA Separators
Manufacturing

Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide

CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
Research & Development

OGT launches new SureSeq myeloid fusion panel drive myeloid cancer research

The assay enables users to integrate research techniques with a single, streamlined NGS process, expediting the process
Subscribe now